FDA Inspection 1279096 — Spera Nexus, Inc.
The FDA completed an inspection of Spera Nexus, Inc. on July 10, 2025 in Kakegawa. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kakegawa (Japan)